Roche Holding’s results showed a slower-than-expected recovery for eye blockbuster Vabysmo as investors look to a key new drug to power growth ahead.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-07-23/roche-second-quarter-sales-blockbuster-eye-drug)